Effect of Coenzyme Q10 on Insulin Resistance in Korean Patients with Prediabetes: A Pilot Single-Center, Randomized, Double-Blind, Placebo-Controlled Study.

Published in: BioMed research international (2018)

Patients with prediabetes who were administered coenzyme Q10 showed a significant reduction in HOMA-IR values. Therefore, administration of coenzyme Q10 in patients with impaired glucose tolerance may slow the progression from prediabetes to overt diabetes.

Keyphrases

double blind
placebo controlled
clinical trial
study protocol
phase iii
type diabetes
phase ii
open label
randomized controlled trial
metabolic syndrome